Picture of aTyr Pharma logo

ATYR — aTyr Pharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: aTyr Pharma Inc Believes Cash Runway Will Extend Into 2026

March 9 (Reuters) - aTyr Pharma Inc  LIFE.O :
    * ATYR PHARMA ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022
RESULTS
AND PROVIDES CORPORATE UPDATE
    * ATYR PHARMA INC - BASED ON COMPANY'S CURRENT OPERATIONAL
PLANS
AND EXISTING CASH, ATYR BELIEVES COMPANY'S CASH RUNWAY WILL
EXTEND INTO 2026
    * ATYR PHARMA INC - QTRLY NET LOSS PER SHARE, BASIC AND
DILUTED
$0.26

Source text for Eikon:  ID:nGNX3lX9fl 
Further company coverage:  LIFE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on aTyr Pharma

See all news